Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 006620494 approvals106 trials

DongKoo Bio & Pharma Co., Ltd.

Official website

KOSDAQ-listed pharmaceutical company producing dermatology and urology drugs including Dermotasone MLE and Eurofa SR.

As of 2026-10-10, DongKoo Bio & Pharma Co., Ltd. has 1 Korean MFDS device approval, 493 Korean MFDS drug approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1983 and listed on KOSDAQ in 2018, DongKoo Bio & Pharma is a comprehensive pharmaceutical company centered on dermatology and urology finished drugs. It offers prescription drugs including Dermotasone MLE, Cycrin soft capsules, Eurofa SR, Eurolid, Alestin, and Cravix alongside CMO, medical device, and cosmetics businesses, and also operates a new-technology venture financing business through its wholly owned subsidiary Lofty Rock Investment. 2025 annual revenue was KRW 230.6 billion for the pharmaceutical and quasi-drug segment and KRW 12.3 billion for the new-technology financing segment (Lofty Rock Investment).

Products & technology

  • Dermotasone MLE, Cycrin, Eurofa SR, Eurolid, Acostan, Alestin, Cravix, etc.Dermatology and urology prescription drugs
  • Mediblum MD lotion/cream, Cell BloomCosmetics

Regulatory approvals

data.go.kr

493 Korean MFDS drug approvals · 1975–2026 / 1 Korean MFDS device approvals · 2024

  • MFDS drugPenmiron Capsule (Pentosan Polysulfate Sodium)2026-09-18
    Drug · Prescription · Approval202602821
  • MFDS drugFimaTri Tab. 60/2.5/10mg2026-09-16
    Drug · Prescription · Approval202602799
  • MFDS drugVonopro Tab. 10mg2026-06-23
    Drug · Prescription · Approval202601769
  • MFDS drugVonopro Tab. 20mg2026-06-23
    Drug · Prescription · Approval202601770
  • MFDS drugPelbipen Tab. 30mg2026-06-11
    Drug · Prescription · Approval202601658
  • MFDS drugDoneforce Duo Tab. 10/20mg2026-05-14
    Drug · Prescription · Approval202601417
  • MFDS drugPrankas Tab. 50mg (Pranlukast Hydrate)2026-04-07
    Drug · Prescription · Approval202600968
  • MFDS drugCentelladin Ointment2026-02-03
    Drug · OTC · Notification202600305
  • MFDS drugFuciderma Ointment2026-02-03
    Drug · OTC · Notification202600306
  • MFDS drugProzosin Tab. 5mg2025-07-14
    Drug · Prescription · Approval202501775
  • MFDS drugDongkoo Levocin Tab. 250mg2025-05-08
    Drug · Prescription · Approval202501122
  • MFDS drugEmpanceduo XR Tab. 5/1000mg2025-03-25
    Drug · Prescription · Approval202500684
Show 68 more
  • MFDS drugEmpanceduo XR Tab. 10/1000mg2025-03-25
    Drug · Prescription · Approval202500685
  • MFDS drugEmpanceduo XR Tab. 12.5/1000mg2025-03-25
    Drug · Prescription · Approval202500686
  • MFDS drugEmpanceduo XR Tab. 25/1000mg2025-03-25
    Drug · Prescription · Approval202500687
  • MFDS drugSitaflozinmet SR Tab. 5/50/1000mg2025-03-12
    Drug · Prescription · Approval202500552
  • MFDS drugUROGUARD Tab. 0.5/5mg2025-01-23
    Drug · Prescription · Approval202500182
  • MFDS drugSitaflozinmet SR Tab. 10/100/1000mg2024-12-31
    Drug · Prescription · Approval202403106
  • MFDS drugDongKoo Acyclovir Cream2024-12-30
    Drug · OTC · Notification202403097
  • MFDS drugTramela Cap.2024-12-09
    Drug · Prescription · Approval202402900
  • MFDS drugSMETHRIN cream2024-11-20
    Drug · Prescription · Notification202402735
  • MFDS drugCircuload Tab. 240mg2024-10-16
    Drug · OTC · Notification202402443
  • MFDS drugZygra Tab. 50mg2024-07-15
    Drug · Prescription · Approval202401725
  • MFDS drugEfinazole Topical Sol.2024-07-08
    Drug · Prescription · Approval202401661
  • MFDS drugDomo-horn solution 0.05%Revoked2024-06-28
    Drug · Prescription · Notification202401574
  • MFDS drugGUCCE Tab. 15/50mg2024-05-16
    Drug · Prescription · Approval202401196
  • MFDS drugOtemila Tab.2024-04-17
    Drug · Prescription · Approval202400870
  • MFDSFat separator, filter2024-04-03
    Product approval · Class 3제허 24-238 호
  • MFDS drugLinatop-duo XR tab. 5/1000mg2024-03-22
    Drug · Prescription · Approval202400604
  • MFDS drugLinatop-duo XR tab. 2.5/1000mg2024-03-22
    Drug · Prescription · Approval202400605
  • MFDS drugAC Cure MLE Gel2024-03-21
    Drug · Prescription · Approval202400584
  • MFDS drugCernilton A Cap.2024-02-16
    Drug · OTC · Approval202400340
  • MFDS drugTradiance Tab. 25/5mg2023-09-27
    Drug · Prescription · Approval202302839
  • MFDS drugTradiance Tab. 10/5mg2023-09-27
    Drug · Prescription · Approval202302840
  • MFDS drugLevokas Tab.(Montelukast Sodium.Levocetirizine hydrochloride)2023-08-23
    Drug · Prescription · Approval202302488
  • MFDS drugEmpanceduo Tab. 12.5/850mg2023-07-31
    Drug · Prescription · Approval202302303
  • MFDS drugEmpanceduo Tab. 12.5/500mg2023-07-31
    Drug · Prescription · Approval202302304
  • MFDS drugEmpanceduo Tab. 12.5/1000mg2023-07-31
    Drug · Prescription · Approval202302305
  • MFDS drugAcberi 1% Cream2023-07-18
    Drug · Prescription · Approval202302179
  • MFDS drugDextisone Cream2023-05-01
    Drug · OTC · Approval202301413
  • MFDS drugS-karb Tab. 60/5mg2023-01-05
    Drug · Prescription · Approval202300053
  • MFDS drugS-karb Tab. 30/2.5mg2023-01-05
    Drug · Prescription · Approval202300054
  • MFDS drugS-karb Tab. 60/2.5mg2023-01-05
    Drug · Prescription · Approval202300055
  • MFDS drugGlisitamet Tab. 50/850mg2022-12-21
    Drug · Prescription · Approval202204579
  • MFDS drugGlisitamet Tab. 50/500mg2022-12-21
    Drug · Prescription · Approval202204580
  • MFDS drugGlisitamet Tab. 50/1000mg2022-12-21
    Drug · Prescription · Approval202204581
  • MFDS drugBepotin SR Tab.(Bepotastine besilate)2022-12-16
    Drug · Prescription · Approval202204507
  • MFDS drugDapaprozinMet XR Tab. 5/500mg2022-12-05
    Drug · Prescription · Approval202204356
  • MFDS drugDapaprozinMet XR Tab. 5/1000mg2022-12-05
    Drug · Prescription · Approval202204357
  • MFDS drugDapaprozinMet XR Tab. 10/500mg2022-12-05
    Drug · Prescription · Approval202204358
  • MFDS drugDapaprozinMet XR Tab. 10/1000mg2022-12-05
    Drug · Prescription · Approval202204359
  • MFDS drugDongkoo dutalid soft capsules(Dutasteride)2022-12-02
    Drug · Prescription · Approval202204330
  • MFDS drugMeniace-S Tab. 24mg2022-11-15
    Drug · Prescription · Notification202204108
  • MFDS drugTrenon Soft Cap. 5mg2022-10-31
    Drug · Prescription · Approval202203947
  • MFDS drugAirfenac Duo Tab.2022-09-27
    Drug · Prescription · Approval202203690
  • MFDS drugGlisitamet XR Tab. 50/500mg2022-05-11
    Drug · Prescription · Approval202201952
  • MFDS drugGlisitamet XR Tab. 50/1000mg2022-05-11
    Drug · Prescription · Approval202201953
  • MFDS drugGlisitamet XR Tab. 100/1000mg2022-05-11
    Drug · Prescription · Approval202201954
  • MFDS drugEmpanceduo Tab.5/500mg2022-04-04
    Drug · Prescription · Approval202201297
  • MFDS drugEmpanceduo Tab.5/1000mg2022-04-04
    Drug · Prescription · Approval202201298
  • MFDS drugEmpanceduo Tab.5/850mg2022-04-04
    Drug · Prescription · Approval202201299
  • MFDS drugDapaprozin Tablets 5mg2022-02-23
    Drug · Prescription · Approval202200812
  • MFDS drugDapaprozin Tablets 10mg2022-01-04
    Drug · Prescription · Approval202200034
  • MFDS drugSitaflozin tab 10/100mg2021-12-23
    Drug · Prescription · Approval202108076
  • MFDS drugCycrine Soft Cap. 25mg2021-11-17
    Drug · Prescription · Approval202107542
  • MFDS drugCycrine Soft Cap. 50mg2021-11-16
    Drug · Prescription · Approval202107512
  • MFDS drugPROCOUGH CR Tab2021-06-30
    Drug · Prescription · Approval202104980
  • MFDS drugDongkoo Vildagliptin tab. 50mg2021-04-16
    Drug · Prescription · Approval202103149
  • MFDS drugDoneforce Tab. 23mgRevoked2021-04-05
    Drug · Prescription · Approval202102920
  • MFDS drugDongkoo Rivaroxaban Tab. 15mgRevoked2021-03-22
    Drug · Prescription · Approval202102475
  • MFDS drugDongkoo Rivaroxaban Tab. 10mgRevoked2021-03-22
    Drug · Prescription · Approval202102476
  • MFDS drugGlisita Tab. 50mg2021-03-17
    Drug · Prescription · Approval202102395
  • MFDS drugGlisita Tab. 25mg2021-03-17
    Drug · Prescription · Approval202102396
  • MFDS drugGlisita Tab. 100mg2021-03-17
    Drug · Prescription · Approval202102397
  • MFDS drugEmpance Tab. 25mg2021-02-24
    Drug · Prescription · Approval202101834
  • MFDS drugEmpance Tab. 10mg2021-02-24
    Drug · Prescription · Approval202101835
  • MFDS drugZetstan tab. 10/20mg2021-02-18
    Drug · Prescription · Approval202101387
  • MFDS drugZetstan tab. 10/40mg2021-02-18
    Drug · Prescription · Approval202101388
  • MFDS drugZetstan tab. 10/10mg2021-02-18
    Drug · Prescription · Approval202101389
  • MFDS drugMirabega PR Tab. 50mg2021-02-18
    Drug · Prescription · Approval202101447

Showing the 80 most recent of 494 records.

Clinical trials

data.go.kr

106 MFDS clinical trial authorisations · 2014–2026 (Bioequivalence 83 · Phase 1 21 · Phase 3 2)

  • Bioequivalence6KOPE02026-09-04

    2 trial sites

  • Bioequivalence6KODT02026-07-24

    2 trial sites

  • Bioequivalence6KODT02026-07-24

    2 trial sites

  • Phase 16KODT02026-05-22

    2 trial sites

  • Phase 16KODT02026-05-21

    2 trial sites

  • Bioequivalence6KOPE02026-03-09

    2 trial sites

  • Bioequivalence5DOOS02026-03-03

    2 trial sites

  • Bioequivalence3DOOE02026-02-25

    2 trial sites

  • Bioequivalence3DOOE02026-02-25

    2 trial sites

  • Phase 15KORE02026-02-19

    2 trial sites

  • Phase 15BFAR02025-05-20

    2 trial sites

  • Bioequivalence5KODM02025-05-07

    2 trial sites

Show 68 more
  • Phase 15KORE02025-04-02

    2 trial sites

  • Bioequivalence4DOOP12025-01-24

    2 trial sites

  • Bioequivalence4DOOP02024-06-12

    2 trial sites

  • Bioequivalence3DOOE02024-04-09

    2 trial sites

  • Bioequivalence3DOOE02024-04-08

    2 trial sites

  • Bioequivalence3DOOT1012024-02-19

    2 trial sites

  • Bioequivalence3DOOV0012023-11-24

    2 trial sites

  • Bioequivalence3DOOT0012023-09-26

    2 trial sites

  • Phase 15BFAR02023-07-28

    2 trial sites

  • Phase 1TAR2023-07-10

    2 trial sites

  • Phase 1DSM2023-06-27

    2 trial sites

  • Phase 1DSM2023-06-23

    2 trial sites

  • Phase 1OEM2023-06-01

    2 trial sites

  • Phase 1OEM2023-05-25

    2 trial sites

  • BioequivalenceOOB2023-04-24

    2 trial sites

  • Phase 1OOF2023-04-20

    2 trial sites

  • Phase 1DKB210032022-12-01

    2 trial sites

  • Phase 1DKB210032022-11-24

    2 trial sites

  • BioequivalenceDKB2207-T2022-11-17

    2 trial sites

  • BioequivalenceDKB2206-T2022-11-17

    2 trial sites

  • BioequivalenceDKB2203-T2022-06-24

    2 trial sites

  • BioequivalenceDKB2202-T2022-06-24

    2 trial sites

  • BioequivalenceDKB2201-T2022-05-13

    2 trial sites

  • BioequivalenceDKB2009-T2022-01-27

    2 trial sites

  • BioequivalenceDKB2105-T2021-12-06

    2 trial sites

  • BioequivalenceDKB2102-T2021-12-01

    1 trial site

  • BioequivalenceDKB2014-T2021-11-02

    2 trial sites

  • BioequivalenceDKB2015-T2021-08-17

    2 trial sites

  • BioequivalenceDKB2015-T2021-08-17

    2 trial sites

  • BioequivalenceDKB2016-T2021-08-17

    2 trial sites

  • BioequivalenceDKB2016-T2021-08-13

    2 trial sites

  • BioequivalenceDKB2103-T2021-08-12

    2 trial sites

  • Phase 1DKB210012021-07-16

    2 trial sites

  • BioequivalenceDKB2009-T2021-06-16

    2 trial sites

  • BioequivalenceDKB2101-T2021-05-07

    2 trial sites

  • Phase 1DKB190032021-03-02

    2 trial sites

  • Phase 3DKB170012021-01-29

    2 trial sites

  • BioequivalenceDKB2017-T2021-01-14

    2 trial sites

  • BioequivalenceDKB2014-T2020-12-07

    2 trial sites

  • BioequivalenceDKB2013-T2020-11-25

    1 trial site

  • BioequivalenceDKB2008-T2020-11-20

    2 trial sites

  • BioequivalenceDKB2010-T2020-11-16

    2 trial sites

  • BioequivalenceDKB2011-T2020-09-29

    1 trial site

  • Bioequivalence라모난정(테르비나핀염산염)2020-09-11

    2 trial sites

  • BioequivalenceDKB2009-T2020-09-09

    2 trial sites

  • BioequivalenceDKB2002-T2020-07-23

    1 trial site

  • Phase 1DKB190032020-07-07

    2 trial sites

  • BioequivalenceDKB2007-T2020-07-02

    2 trial sites

  • BioequivalenceDKB2006-T2020-06-24

    2 trial sites

  • BioequivalenceDKB2005-T2020-06-24

    2 trial sites

  • BioequivalenceDKB2003-T2020-06-24

    2 trial sites

  • BioequivalenceDKB20012020-06-08

    2 trial sites

  • Phase 1DKB190022020-05-06

    1 trial site

  • Bioequivalence트레논연질캡슐(이소트레티노인)2020-03-24

    2 trial sites

  • Bioequivalence사이크린연질캡슐100밀리그램(사이클로스포린)2019-09-30

    2 trial sites

  • Bioequivalence제트스탄정10/40밀리그램2019-09-30

    2 trial sites

  • Phase 1DKB150022019-09-27

    1 trial site

  • BioequivalenceDKB2014-T2019-09-23

    2 trial sites

  • Bioequivalence라모난정(테르비나핀염산염)2019-09-23

    2 trial sites

  • Bioequivalence엠파앙듀오정5/1000밀리그램(메트포르민염산염, 엠파글리플로진)2019-09-05

    2 trial sites

  • Bioequivalence푸로조신정2밀리그람(테라조신염산염수화물)2019-08-09

    2 trial sites

  • Bioequivalence디코나졸캡슐50mg(플루코나졸)2019-07-31

    2 trial sites

  • Bioequivalence엠파앙정25밀리그램(엠파글리플로진)2019-07-26

    2 trial sites

  • Bioequivalence미라베가서방정50밀리그램(미라베그론)2019-07-17

    2 trial sites

  • Bioequivalence미라베가서방정50밀리그램(미라베그론)2019-07-17

    2 trial sites

  • Bioequivalence록소리스정(록소프로펜나트륨수화물)2019-06-24

    2 trial sites

  • Bioequivalence사포그렌서방정300밀리그램(사르포그렐레이트염산염)2019-04-16

    1 trial site

  • Bioequivalence사포그렌서방정300밀리그램(사르포그렐레이트염산염)2019-04-16

    2 trial sites

Showing the 80 most recent of 106 records.

Global clinical trials

ClinicalTrials.gov · sponsor-matched

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 41 more patents

AI reads

MAA server logs · IP-verified
53
Times AI engines pulled DongKoo Bio & Pharma Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

52
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

7
live 0
Last 7 days
35
live 0
Last 30 days
53
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot43
  • PerplexityPerplexityBot5
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 25, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for DongKoo Bio & Pharma Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition